Elite Clinical Research, LLC

Jackson, Mississippi 39216

0 studies enrolling now · 9 studies all time

What they study most

Chronic Gout, Chronic Kidney Diseases, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Fibromyalgia, Gout, Gout Flare, Hyperuricemia, Primary Prevention of Atherosclerotic Cardiovascular Disease, Tophi

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy II — Completed
• A Study to Assess the Analgesic Efficacy and Safety of ASP8062 in Subjects With Fibromyalgia — Completed
• Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients — Completed
• A Study of SEL-212 in Patients With Gout Refractory to Conventional Therapy — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Study to Compare the Efficacy of SEL-212 to KRYSTEXXA® in Gout Participants Refractory to Conventional Therapy — Completed
• Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease — Stopped early